Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Exelon Corporation, 3 years.
Exelon Corporation
Director
AFLAC Incorporated
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AFLAC Incorporated May 4, 202698.2%
-
AFLAC Incorporated May 5, 202598.3%
-
AFLAC Incorporated May 6, 202499.0%
-
AFLAC Incorporated May 1, 202399.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 4, 2026 | AFLAC Incorporated | Grant or award | +3,795 | — | — |
| Mar 31, 2026 | Exelon Corporation | Grant or award | +878 | $49.82 | $43,742 |
| Dec 31, 2025 | Exelon Corporation | Grant or award | +940 | $43.87 | $41,238 |
| Sep 30, 2025 | Exelon Corporation | Grant or award | +950 | $43.43 | $41,259 |
| Jun 30, 2025 | Exelon Corporation | Grant or award | +954 | $43.25 | $41,261 |
| May 5, 2025 | AFLAC Incorporated | Grant or award | +3,831 | — | — |
| Mar 31, 2025 | Exelon Corporation | Grant or award | +933 | $44.19 | $41,229 |
| Dec 31, 2024 | Exelon Corporation | Grant or award | +1,119 | $36.87 | $41,258 |
| Sep 30, 2024 | Exelon Corporation | Grant or award | +1,025 | $40.23 | $41,236 |
| Jun 30, 2024 | Exelon Corporation | Grant or award | +1,161 | $35.54 | $41,262 |
| May 6, 2024 | AFLAC Incorporated | Grant or award | +4,781 | — | — |
| Mar 31, 2024 | Exelon Corporation | Grant or award | +1,131 | $36.48 | $41,259 |
| Feb 5, 2024 | AFLAC Incorporated | Open-market purchase | +1,500 | $76.00 | $114,000 |
| Dec 31, 2023 | Exelon Corporation | Grant or award | +1,052 | $39.21 | $41,249 |
| Nov 2, 2023 | AFLAC Incorporated | Option exercise | +23,701 | $35.75 | $847,311 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.